Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.48 -0.01 (-2.48%)
As of: Nov 11, 2026 · 3:57 PM EST

Citius Pharmaceuticals (CTXR) Construction in Progress (2016)

Updated

Citius Pharmaceuticals (CTXR) posted Construction in Progress of $19.4 million for fiscal Q2 2016 (quarter ended Mar 31, 2016).

Analysis

Citius Pharmaceuticals (CTXR) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Citius Pharmaceuticals 13.45 Mn -10.82 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 19.40 Mn
API Access

Citius Pharmaceuticals Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=CTXR&period=max&api_key=YOUR_API_KEY